KB Financial Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

KB Financial Partners’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2K	Buy	+5	New	+$1.93K	﹤0.01%	488
2023 Q2	–	Sell	-5	Closed	-$2K	–	606
2023 Q1	$2K	Buy	+5	New	+$2.34K	﹤0.01%	493
2022 Q3	–	Sell	-3	Closed	-$1K	–	583
2022 Q2	$1K	Buy	+3	New	+$1.56K	﹤0.01%	553
2022 Q1	–	Sell	-2	Closed	-$2K	–	606
2021 Q4	$2K	Sell	2 -272	-99%	-$204K	﹤0.01%	573
2021 Q3	$204K	Buy	274 +27	+11%	+$20.2K	0.07%	160
2021 Q2	$159K	Buy	+247	New	+$150K	0.06%	176

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KB Financial Partners's BIO Position: Q3 2023 in Review

KB Financial Partners opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2023: 5 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #488 among its holdings. This is a return to the name: KB Financial Partners previously reported a position in BIO as recently as Q1 2023.

KB Financial Partners first reported a position in BIO in Q2 2021 and has held it in 6 quarters since. The position peaked at $204K in Q3 2021. 467 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

KB Financial Partners held 5 shares of Bio-Rad Laboratories Class A worth $2K as of Q3 2023.
Bio-Rad Laboratories Class A was a new KB Financial Partners position in Q3 2023.
Bio-Rad Laboratories Class A made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #488 holding.
KB Financial Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and has held it in 6 quarters since.
KB Financial Partners's Bio-Rad Laboratories Class A position peaked at $204K in Q3 2021.
467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.